VT02956 |
| Catalog No.GC70131 |
VT02956 es un inhibidor de LATS (IC50: LATS1 0.76 nM, LATS2 0.52 nM). VT02956 se dirige a la vía de señalización Hippo. VT02956 inhibe el crecimiento de líneas celulares de cáncer de mama ER+ y órganos tumorales derivados de pacientes, así como la expresión de ESR1.
Products are for research use only. Not for human use. We do not sell to patients.
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Review for VT02956
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)
Review for VT02956
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *